Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corp.  shares spiked more than 10% higher in after-hours trading Wednesday after reports that it is preparing to acquire U.S.

Canopy Growth stock climbs more than 10% after report of potential merger with U.S. pot company

Marijuana stocks rose late Wednesday on a report that Canada's Canopy Growth is said to be close to a deal to buy U.S. pot grower Acreage Holdings.

Pot Stock Canopy Growth Near Deal To Buy Acreage Holdings: Report

Canadian cannabis giant Canopy Growth is close to a deal to purchase Acreage Holdings, sources familiar with the deal told CNBC.

Weed giant Canopy Growth closing in on deal to buy Acreage Holdings

Aurora Cannabis

Cronos Group

HEXO Corp

The cannabis sector received one of its biggest votes of confidence yet from Wall Street on Wednesday when a top firm initiated coverage on four cannabis stocks.

Bank Of America Initiates Coverage On Cannabis Stocks, Names Surprising Top Pick

Merrill Lynch has started coverage of the legalized cannabis industry with a mostly positive view.

Merrill Lynch Jumps on Legalized Cannabis Train, Sees Large Potential Upside

Aphria

Tilray Brands

Canopy Growth's next quarterly update might not be nearly as rosy as its last one. And the situation could be even worse for other marijuana producers.

Why 1 Analyst Just Slashed Revenue Estimates for Canopy Growth -- and What It Could Mean for Other Marijuana Stocks

Wall Street portends trouble ahead for the largest pot stock in the world.

1 Figure That Should Have Marijuana Stock Investors Concerned

Canopy Growth is widely considered to be the market leader in the growing cannabis space.

Canopy Growth's Revenue Could Shrink, And That's OK

Canopy Growth Corp shares surged more than 4 percent after co-CEO Bruce Linton updated the company’s fiscal 2020 revenue guidance Tuesday at the GMP Securities cannabis conference in Toronto.

Canopy Growth Soars On Unexpected Guidance Update, European Acquisition

Sweden's public pension fund has gone to pot.

Why Sweden's Government Bought Aurora Cannabis and Canopy Growth Stock

Could the reasons behind Aphria's dismal Q3 results bite Aurora Cannabis, Canopy Growth, and others in their next quarterly updates?

What Aphria's Poor Performance Could Mean for Other Canadian Marijuana Stocks

Quest Diagnostics' Drug Testing Index highlights a potentially worrisome trend.

Should We Blame Marijuana for a 14-Year High in Positive Work-Related Drug Tests?

Profits could be a lot tougher to come by than investors realize.

Earnings Estimates Are Tumbling for These Pot Stocks

Here are the pros and cons you need to know before buying the big Canadian marijuana stock.

Is Canopy Growth (CGC) a Buy?

Two out of three Americans favor legalizing marijuana. So, why hasn't that happened yet?

Why Is Legalizing Pot Proving So Difficult in the United States?

Cannabis brand Canopy Growth Corporation announced it will join the S&P/TSX 60 Index, replacing Goldcorp Inc. on the Index.

Canopy Growth To Replace Goldcorp In The S&P/TSX 60 Index

Shares of Canopy Growth Corp.  surged 3.9% in premarket trade Friday, to bounce off the previous session's 3-month closing low, after Canada-based cannabis company said it will join the S&P/TSX 60 Index.

Canopy Growth to join the S&P/TSX 60 large-cap index, stock surges

These pot stocks come closest to meeting the S&P 500's stringent inclusion requirements.

2 Marijuana Stocks That Could Be Added to the S&P 500

Gloomy views of these businesses sent their stocks lower.

Why Canopy Growth Slumped Today

Scotts Miracle-Gro

Cannabis stocks had a huge showing on Wall Street this past fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them. Some of the stocks even doubled or tripled in value in this time.

Short Sellers Getting Higher on Cannabis Stocks

Though tight-lipped on output, here's a road map of how Canopy can become one of Canada's biggest cannabis producers.

A Detailed Look at How Canopy Growth Tops 500,000 Kilos in Peak Annual Production

On Oct. 17, 2018, Canada made history by becoming the first G7 country and the second country overall to legalize adult-use cannabis.

Study Says Canadian Cannabis Market Could Reach $5.2B By 2024: 4 Provinces To Watch

These brand-name pot stocks have some pretty glaring deficiencies.

Here's Why the 5 Most Popular Marijuana Stocks Aren't Worth Buying

GW Pharmaceuticals

Innovative Industrial Properties

According to Arcview Market Research and BDS Analytics, global consumer marijuana outlays are estimated to climb 38% to $16.9 billion this year, up from a projected $12.2 billion last year, $9.5 billion in 2017, and $6.9 billion in 2016.

4 Marijuana Stocks to Watch in 2019

Constellation Brands

Constellation Brands have been continuously adding to their stake in Canopy Growth, which is the leading player in the Canadian cannabis market. STZ just added another $4 billion investment in August bringing its total stake in Canopy to 38% ownership.

News for Canopy Growth Stock (CGC)